Third Consecutive Year of Double Digit Growth - Herbal Dispatch Recaps Key Milestones for 2025

Executive Summary

• Herbal Dispatch reported double‑digit annual sales growth for the third consecutive year, with FY 2025 gross sales of $16.5 M (+38% YoY).
• Q4 2025 preliminary gross sales jumped to $6.2 M, a 214% increase over Q4 2024.
• The company completed an oversubscribed $2 M private placement in October 2025 to fund its 2026 growth initiatives.

Key Details

• FY 2025 Gross Sales: $16.5 million (up 38% from $12.0 million in FY 2024).
• Q4 2025 Preliminary Gross Sales: $6.2 million, a 214% increase versus Q4 2024 ($2.9 million).
• Sales Growth Trend: Three consecutive years of double‑digit annual sales growth.
• Private Placement: Completed an oversubscribed private placement raising $2 million in October 2025; proceeds earmarked for growth initiatives.
• New Product Launches: Introduced several in‑house brands (flower, pre‑rolls, vape) to the Canadian market during 2025.
• Strategic Priorities for 2026:
• Expand medical cannabis sales to veterans – target 30% YoY growth in veteran customer acquisition, retention > 89%.
• Grow recreational sales – aim for 40% YoY increase, expand SKU count in BC from 44 to >100, achieve 15% market share in BC.
• Accelerate B2B exports – goal to triple export volumes by 2028, add 2‑3 new international markets annually, pursue 100% YoY export revenue growth.

Notable Quotes

• “2025 marked a pivotal year for Herbal Dispatch as we continued to accelerate our growth and solidify our market presence in Canada and overseas,” said Philip Campbell, CEO.
• “With strong sales momentum and a clear strategic roadmap ahead, we are well‑positioned for sustained growth and new opportunities.” – Philip Campbell, CEO.